α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer

被引:440
作者
Fauvet, Bruno [1 ]
Mbefo, Martial K. [1 ]
Fares, Mohamed-Bilal [1 ]
Desobry, Carole [1 ]
Michael, Sarah [2 ]
Ardah, Mustafa T. [3 ]
Tsika, Elpida [4 ]
Coune, Philippe [5 ]
Prudent, Michel [6 ]
Lion, Niels [6 ]
Eliezer, David [7 ,8 ]
Moore, Darren J. [4 ]
Schneider, Bernard [5 ]
Aebischer, Patrick [5 ]
El-Agnaf, Omar M. [3 ]
Masliah, Eliezer [2 ]
Lashuel, Hilal A. [1 ]
机构
[1] Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Sch Life Sci, Brain Mind Inst,Stn 19, CH-1015 Lausanne, Switzerland
[2] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA
[3] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain 15551, U Arab Emirates
[4] Ecole Polytech Fed Lausanne, Lab Mol Neurodegenerat Res, CH-1015 Lausanne, Switzerland
[5] Ecole Polytech Fed Lausanne, Neurodegenerat Dis Lab, CH-1015 Lausanne, Switzerland
[6] Serv Reg Vaudois Transfus Sanguine, CH-1066 Epalinges, Switzerland
[7] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA
[8] Weill Cornell Med Coll, Program Struct Biol, New York, NY 10065 USA
基金
瑞士国家科学基金会; 美国国家卫生研究院;
关键词
GLUTATHIONE-S-TRANSFERASE; FAMILIAL PARKINSONS-DISEASE; IN-VITRO; 3-DIMENSIONAL STRUCTURE; SELF-OLIGOMERIZATION; ALZHEIMERS-DISEASE; RESIDUAL STRUCTURE; TRANSGENIC MICE; EXTENDED-HELIX; CROSS-LINKING;
D O I
10.1074/jbc.M111.318949
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since the discovery and isolation of alpha-synuclein (alpha-syn) from human brains, it has been widely accepted that it exists as an intrinsically disordered monomeric protein. Two recent studies suggested that alpha-syn produced in Escherichia coli or isolated from mammalian cells and red blood cells exists predominantly as a tetramer that is rich in alpha-helical structure (Bartels, T., Choi, J. G., and Selkoe, D. J. (2011) Nature 477, 107-110; Wang, W., Perovic, I., Chittuluru, J., Kaganovich, A., Nguyen, L. T. T., Liao, J., Auclair, J. R., Johnson, D., Landeru, A., Simorellis, A. K., Ju, S., Cookson, M. R., Asturias, F. J., Agar, J. N., Webb, B. N., Kang, C., Ringe, D., Petsko, G. A., Pochapsky, T. C., and Hoang, Q. Q. (2011) Proc. Natl. Acad. Sci. 108, 17797-17802). However, it remains unknown whether or not this putative tetramer is the main physiological form of alpha-syn in the brain. In this study, we investigated the oligomeric state of alpha-syn in mouse, rat, and human brains. To assess the conformational and oligomeric state of native alpha-syn in complex mixtures, we generated alpha-syn standards of known quaternary structure and conformational properties and compared the behavior of endogenously expressed alpha-syn to these standards using native and denaturing gel electrophoresis techniques, size-exclusion chromatography, and an oligomer-specific ELISA. Our findings demonstrate that both human and rodent alpha-syn expressed in the central nervous system exist predominantly as an unfolded monomer. Similar results were observed when human alpha-syn was expressed in mouse and rat brains as well as mammalian cell lines (HEK293, HeLa, and SH-SY5Y). Furthermore, we show that alpha-syn expressed in E. coli and purified under denaturing or nondenaturing conditions, whether as a free protein or as a fusion construct with GST, is monomeric and adopts a disordered conformation after GST removal. These results do not rule out the possibility that alpha-syn becomes structured upon interaction with other proteins and/or biological membranes.
引用
收藏
页码:15345 / 15364
页数:20
相关论文
共 73 条
[1]   Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease [J].
Anderson, John P. ;
Walker, Donald E. ;
Goldstein, Jason M. ;
de laat, Rian ;
Banducci, Kelly ;
Caccavello, Russell J. ;
Barbour, Robin ;
Huang, Jiping ;
Kling, Kristin ;
Lee, Michael ;
Diep, Linnea ;
Keim, Pamela S. ;
Shen, Xiaofeng ;
Chataway, Tim ;
Schlossmacher, Michael G. ;
Seubert, Peter ;
Schenk, Dale ;
Sinha, Sukanto ;
Gai, Wei Ping ;
Chilcote, Tamie J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (40) :29739-29752
[2]   Identification of a helical intermediate in trifluoroethanol-induced alpha-synuclein aggregation [J].
Anderson, Valerie L. ;
Ramlall, Trudy F. ;
Rospigliosi, Carla C. ;
Webb, Watt W. ;
Eliezer, David .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (44) :18850-18855
[3]  
Baba M, 1998, AM J PATHOL, V152, P879
[4]   α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation [J].
Bartels, Tim ;
Choi, Joanna G. ;
Selkoe, Dennis J. .
NATURE, 2011, 477 (7362) :107-U123
[5]   Familial mutants of α-synuclein with increased neurotoxicity have a destabilized conformation [J].
Bertoncini, CW ;
Fernandez, CO ;
Griesinger, C ;
Jovin, TM ;
Zweckstetter, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (35) :30649-30652
[6]   Interaction of α-synuclein with divalent metal ions reveals key differences:: A link between structure, binding specificity and fibrillation enhancement [J].
Binolfi, Andres ;
Rasia, Rodolfo M. ;
Bertoncini, Carlos W. ;
Ceolin, Marcelo ;
Zweckstetter, Markus ;
Griesinger, Christian ;
Jovin, Thomas M. ;
Fernandez, Claudio O. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (30) :9893-9901
[7]   Residual structure and dynamics in Parkinson's disease-associated mutants of α-synuclein [J].
Bussell, R ;
Eliezer, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (49) :45996-46003
[8]   α-synuclein locus duplication as a cause of familial Parkinson's disease [J].
Chartier-Harlin, MC ;
Kachergus, J ;
Roumier, C ;
Mouroux, V ;
Douay, X ;
Lincoln, S ;
Levecque, C ;
Larvor, L ;
Andrieux, J ;
Hulihan, M ;
Waucquier, N ;
Defebvre, L ;
Amouyel, P ;
Farrer, M ;
Destée, A .
LANCET, 2004, 364 (9440) :1167-1169
[9]   Lipid droplet binding and oligomerization properties of the Parkinson's disease protein α-synuclein [J].
Cole, NB ;
Murphy, DD ;
Grider, T ;
Rueter, S ;
Brasaemle, D ;
Nussbaum, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :6344-6352
[10]   Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
NATURE MEDICINE, 1998, 4 (11) :1318-1320